CABOTAMIG
UNII 5W7SK85BMU

Substance Identification & Data

This profile provides standardized clinical and technical data for Cabotamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5W7SK85BMU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2755301-09-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5W7SK85BMU
CAS Registry Number
2755301-09-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CABOTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12632
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cabotamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CABOTAMIG

Common Names & Synonyms

CABOTAMIG [INN]
CABOTAMIG [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HUMAN CADHERIN 17) (HUMAN-MUS MUSCULUS HYBRID .GAMMA.1/.GAMMA.4-CHAIN PRECURSOR) FUSION PROTEIN WITH PEPTIDE LINKER (PAGGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS SINGLE-CHAIN FV FRAGMENT VH-(GGGGS)3-VL), DISULFIDE WITH HUMAN .KAPPA.-CHAIN PRECURSOR, DIMER
IMMUNOGLOBULIN VH-G1CH1H-G4CH2CH3-SCFV_L-KAPPA DIMER, ANTI-(HOMO SAPIENS CDH17 (CADHERIN 17)), ANTI-(HOMO SAPIENS CD3E (CD3EPSILON, LEU-4)), MONOCLONAL ANTIBODY HUMANIZED, BISPECIFIC